GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.51 $159.34 Friday, 19th Apr 2024 ALNY stock ended at $144.41. This is 0.517% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 2.38% from a day low at $143.51 to a day high of $146.92.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2024-01-02 $189.88 $196.00 $189.71 $194.93 348 607
2023-12-29 $195.43 $197.02 $191.14 $191.41 269 716
2023-12-28 $196.87 $198.00 $195.18 $195.71 446 123
2023-12-27 $191.43 $196.75 $191.00 $196.57 444 770
2023-12-26 $192.67 $194.89 $190.23 $191.20 305 731
2023-12-22 $183.05 $191.73 $181.67 $191.02 572 609
2023-12-21 $180.83 $182.87 $180.33 $181.14 270 946
2023-12-20 $187.01 $187.01 $178.86 $179.05 646 820
2023-12-19 $187.51 $190.95 $187.06 $187.50 534 322
2023-12-18 $185.63 $189.03 $185.50 $186.23 393 138
2023-12-15 $187.03 $189.92 $183.06 $185.24 1 141 121
2023-12-14 $183.68 $190.98 $183.08 $186.48 1 405 257
2023-12-13 $173.63 $180.94 $173.05 $180.52 782 327
2023-12-12 $172.29 $175.20 $169.83 $173.88 433 048
2023-12-11 $170.04 $173.00 $168.85 $170.92 539 473
2023-12-08 $175.03 $175.03 $170.00 $170.04 452 039
2023-12-07 $176.22 $177.77 $174.39 $177.26 587 715
2023-12-06 $171.00 $176.26 $169.60 $175.02 658 734
2023-12-05 $171.98 $172.00 $169.44 $170.37 246 473
2023-12-04 $170.81 $173.49 $169.77 $172.87 387 361
2023-12-01 $167.93 $171.42 $166.02 $171.41 366 015
2023-11-30 $165.53 $169.65 $165.53 $168.25 719 566
2023-11-29 $161.79 $164.19 $160.18 $164.01 583 567
2023-11-28 $158.09 $161.78 $156.52 $161.36 376 066
2023-11-27 $162.39 $162.50 $159.02 $159.20 628 352
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT